Posts Tagged ‘diabetes’

The attention that goes daily to the subject of preserving muscle and its importance is off the chart. Just this week a call to action about muscle loss in diabetes and a new systematic review on the effects of resistance exercise on cognitive function are demanding our attention. It is clear that preserving muscle as […]

Writer Sarah Jones faces a vivid personal need to reconcile the appealing creed of MAHA with her own recent diagnosis of type 2 diabetes. Confronting a diagnosis she clearly did not want, she found herself blaming herself. She did this despite knowing that the disease is more complicated than a simple blame game. This led […]

The magical Mirror of Erised can drive people mad by showing them their deepest desires. Judging by the flood of papers in recent days, it seems that one such desire is to find consensus for a clinical definition of obesity. In the past week alone, three such publications have crossed our screens. In the past […]

This has been quite a week for easy reading news nuggets about diabetes. First we had the news that Barbie is getting a nifty heart-shaped CGM (continuous glucose monitoring) patch and an insulin pump. Then comes a news blurb from CDC telling us that one in three teens have prediabetes. Should we celebrate the news […]

The annual meeting of the American Society of Clinical Oncology is not where we typically get insights on obesity. But from this year’s meeting, another hint emerges that treating obesity treatment may prevent some of the cancer that arises from obesity. This hint comes from a large and seemingly careful study of 170,030 persons with […]

Is this a grand finale? Or a requiem? In The Lancet Diabetes & Endocrinology yesterday, a new 21-year analysis of outcomes from the Diabetes Prevention Program memorialized an epic study. Even after 21 years, the Diabetes Prevention Program yielded a 24% reduction in the cumulative risk of developing type 2 diabetes, along with detailed outcomes […]

The opening of the American College of Cardiology meeting in Chicago yielded good news on semaglutide from two major studies. A morning presentation  and simultaneous publication in Lancet showed semaglutide reduces symptoms of peripheral artery disease in persons with diabetes. Then, in the afternoon, researchers presented data and published it in the New England Journal […]

Over the last few decades, there have not been a lot of bright spots for metabolic health. But here’s one. A new paper in Diabetes Care tells us diabetes mortality actually dropped between 2000 and 2019. The authors, led by Hasan Nassereldine, suggest that the decline in diabetes deaths could be due to the adoption […]

For persons with obesity and prediabetes, one of the best ways to prevent diabetes onset is quite clear. Treat the obesity to reduce the excess adiposity. The Diabetes Prevention Program established this with a study in the NEJM way back in 2002. A prescription of diet and exercise could cut the risk of diabetes in […]

FDA yesterday approved Ozempic (semaglutide) to prevent kidney failure and death in persons with type 2 diabetes and chronic kidney disease. This fits with one of the five trends for this year: the steady expansion of health benefits for advanced medicines used in obesity and diabetes. But note that this approval covers the use of […]